Quarterly report · Q2
3154.TEDINET S100RJV3
Period2021-07-01 → 2021-12-31
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100NCZC.
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥112.3bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥213.3bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥102.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2020-07-01 → 2020-12-31 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-07-01 → 2020-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-07-01 → 2020-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.1bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥952m | 2020-07-01 → 2020-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Net income | ¥952m | 2020-07-01 → 2020-12-31 | Cons. | Profit loss |
| Total assets | ¥95.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥84.5bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥86.2bn | at 2020-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥78.1bn | at 2021-12-31 | Cons. | Liabilities |
| Total liabilities | ¥68.6bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.2bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.8bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥14.7bn | at 2020-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.7bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.6bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.6bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.0bn | at 2020-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥3.5bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.8bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥554m | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.4bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.0bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.0bn | 2020-07-01 → 2020-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥65.37 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.93 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.81 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.69 | 2020-07-01 → 2020-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.4 | 2020-10-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥65.34 | 2021-07-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥94.15 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.59 | 2020-07-01 → 2020-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 18.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.0% | at 2020-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | −¥3.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥109.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥109.6bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥4.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥278m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2021-12-31 | ¥112.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2021-12-31 | ¥112.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2021-12-31 | ¥5.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2020-12-31 | −¥2.8bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue | 2020-07-01 → 2020-12-31 | ¥99.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2020-07-01 → 2020-12-31 | ¥99.3bn |
| jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2020-07-01 → 2020-12-31 | ¥3.6bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2020-07-01 → 2020-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2020-07-01 → 2020-12-31 | ¥2.8bn |
| jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2020-07-01 → 2020-12-31 | ¥358m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2020-12-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2020-12-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2020-12-31 | ¥4.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 2190000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.0999 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 2188000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0998 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1920000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0876 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1258000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0574 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1111000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0507 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 497000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0227 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 431000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0197 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 396000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0181 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 382000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0175 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 370000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0169 | |
| Number of shares held | CurrentQuarterInstant | 10748000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.4902 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21915200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 219152 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 9004 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 21925104 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 219152 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 12623216000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 12654911000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 43543416000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 49844521000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 9380448000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 10578944000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 10256000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 9296000 | JPY |
| Other ca | Prior1YearInstant | 2725349000 | JPY |
| Other ca | CurrentQuarterInstant | 3365291000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |